Peripheral arterial diseases include conditions that alter the structure or function of extracoronary arteries, with manifestations determined by the territory supplied, the type of lesion and how rapidly it develops. This group includes obstruction of the arteries of the limbs, diseases of the extracranial carotid and vertebral arteries, involvement of the renal and mesenteric vessels, peripheral aneurysms and numerous non-atherosclerotic forms. The word “peripheral” therefore describes a position within the vascular tree, not lesser clinical importance: the consequences may affect walking, limb viability, renal function, the intestine or cerebral perfusion.
It is useful to distinguish this group of disorders from peripheral artery disease, a term most commonly used in clinical practice for predominantly atherosclerotic obstructive arterial disease of the lower limbs. For the latter, an international epidemiological review estimated approximately 236.6 million affected people aged at least 25 years in 2015. This figure concerns a specific population and diagnostic definition and does not represent the overall prevalence of all arteriopathies. Atherosclerotic forms increase markedly with age; dissections, fibromuscular dysplasia, anatomical compression and vasospastic disorders can instead affect young people with very different metabolic profiles.
An arterial lesion can be clinically silent, cause symptoms only when blood demand rises, or present with an acute event. Severity depends not only on the residual vessel lumen: collateral circulation, microvascular adaptive capacity, wall integrity and the possibility of thrombi or atheromatous debris reaching distal sites also matter. In atherosclerotic disease, polyvascular disease is additionally significant because a peripheral lesion may reveal disease involving the coronary arteries or other territories. In non-atherosclerotic disease, identifying the specific mechanism instead helps avoid treatments targeting a cause that is not actually responsible.
Atherosclerosis is the most common cause of obstructive arterial disease in adults, but does not account for all etiologies. Intimal retention of apolipoprotein B-containing lipoproteins promotes lipid accumulation, recruitment of inflammatory cells and transformation of vascular smooth-muscle cells; over time, plaques form with fibrous, lipid-rich and calcified components. Exposure to atherogenic lipoproteins has a causal role, whereas age, diabetes, smoking, hypertension, kidney disease and familial predisposition determine different combinations of susceptibility and disease acceleration. Bifurcations and other segments with disturbed flow are particularly susceptible, although lesion distribution differs among individuals and vascular territories.
Plaque alters the vessel lumen and wall properties, reducing the capacity to increase flow when an organ needs it. Perfusion reserve may already be impaired when resting perfusion remains sufficient: muscle becomes ischemic during walking, while the intestine may become ischemic after a meal. However, stenosis does not automatically cause ischemia, because its effect also depends on lesion length, serial lesions, perfusion pressure and collateral pathways. In the kidney, hypoperfusion can activate the renin–angiotensin–aldosterone system, contributing to hypertension and salt and water retention; sustained loss of function requires parenchymal damage that cannot be inferred solely from the percentage of narrowing.
Thrombosis can turn a compensated chronic disease into a sudden obstruction. The surface of a complicated plaque, endothelial injury or an already diseased arterial segment favors platelet adhesion, thrombin generation and fibrin deposition. An embolus, by contrast, forms elsewhere and reaches the vessel through the bloodstream: it may arise from the heart, an aneurysm or a proximal plaque. This distinction has practical consequences because removing the obstruction does not eliminate the embolic source. Blue toe syndrome also illustrates how distal ischemic injury can coexist with preserved proximal pulses when small-caliber vessels are affected.
In dissection, blood accumulates within the vessel wall and separates its layers. The hematoma may compress the lumen, extend longitudinally or accompany aneurysmal dilation; thrombi capable of causing embolism can form on the altered surface. In cervical arteries, cerebral ischemia often results specifically from artery-to-artery embolization rather than solely from critically reduced flow. Trauma, mechanical stresses and predisposing wall conditions may contribute, but many dissections have no single identifiable cause. Carotid dissection and vertebral artery dissection therefore require a different approach from that applied to an atherosclerotic stenosis of the carotid bulb.
In peripheral artery aneurysms, permanent vessel dilation predominates, supported by changes in the matrix, elastic components and cells of the vessel wall. A true aneurysmal dilation involves the arterial wall, whereas a pseudoaneurysm is a collection communicating with the lumen but contained by structures that do not preserve the complete architecture of the vessel. This distinction points to different etiologies, including traumatic, iatrogenic and infectious lesions. Dilation may create complex flow patterns and mural thrombus, which can result in embolization or occlusion; the importance of rupture varies by location. A popliteal aneurysm, for example, often threatens the limb through thromboembolic complications, whereas some visceral aneurysms are particularly important because of hemorrhagic risk.
Non-atherosclerotic arteriopathies comprise biologically heterogeneous processes. Fibromuscular dysplasia is a non-atherosclerotic, non-inflammatory disease, often involving multiple vascular beds, which may cause focal or multifocal stenoses, aneurysms and dissections. Its etiology is not fully understood: it must not be described as a proven effect of hypertension or as a vasculitis. In true vasculitides, by contrast, inflammation of the vessel wall may cause narrowing, thrombosis or structural weakening; the pattern of involvement by vessel caliber and extravascular manifestations help identify the underlying process.
Thromboangiitis obliterans mainly affects small- and medium-caliber vessels of the limbs and is closely associated with tobacco exposure; inflammatory thrombus and segmental involvement distinguish it from atherosclerotic plaque. Extrinsic compression, such as popliteal artery entrapment and arterial thoracic outlet syndrome, instead begins with an abnormal anatomical or functional relationship between the vessel and surrounding structures. Repeated mechanical trauma can turn initially dynamic compression into intimal injury, stenosis, thrombosis or post-stenotic dilation. Adventitial cystic disease narrows the lumen externally through a lesion of the vessel wall and needs to be recognized precisely because treating a presumed plaque would not resolve its cause.
In Raynaud phenomenon, episodic vasoconstriction of the digital circulation in response to cold or emotional stimuli predominates. The primary form is mainly functional, whereas in secondary forms, especially those associated with systemic sclerosis, vasospasm may overlap with structural vasculopathy. The reversibility of episodes therefore does not justify regarding every case of digital ischemia as benign. Persistent ischemia leads to energy deficit, nerve injury and cellular damage; when resting metabolic needs can no longer be met, rest pain, tissue lesions and necrosis develop. In acute occlusions, this sequence may progress rapidly because there is insufficient time for effective collateral adaptation.
The history should first establish the time of onset, course and relationship of symptoms to organ function. Reproducible muscle pain during walking that is relieved by stopping suggests claudication; sudden pain accompanied by coldness and sensory loss suggests acute interruption of perfusion. In arterial diseases of the limbs, it is essential to distinguish spontaneously reported symptoms from actual functional capacity: someone who has greatly reduced activity may never reach the ischemic threshold and may deny pain despite significant disease. Persistent wounds, color changes, distal nocturnal pain and previous vascular procedures should also be investigated.
Carotid and vertebral artery diseases may remain silent or present with retinal ischemia and focal neurological deficits. Transient loss of vision in one eye, speech disturbance or lateralized motor deficit require an accurate reconstruction of onset, duration and recovery. Isolated dizziness and nonspecific symptoms do not, by themselves, establish symptomatic stenosis. New neck pain or headache, Horner syndrome and neurological signs may instead suggest dissection. Resolution of a deficit does not remove the urgency, because a transient ischemic attack may precede a stroke.
In visceral arterial diseases, the diagnostic question often arises from symptoms that do not initially appear vascular. Postprandial pain, reduced food intake and weight loss make chronic mesenteric ischemia plausible; intense acute abdominal pain, initially disproportionate to the physical findings, requires consideration of an acute mesenteric event. Renal artery stenosis may be suspected in resistant hypertension, deterioration of renal function in suggestive contexts or recurrent episodes of sudden pulmonary edema. None of these findings is specific, and an incidentally discovered stenosis does not automatically establish a causal role.
Further questions concern smoking, diabetes, dyslipidemia, kidney function, previous cardiovascular events, atrial fibrillation, recent procedures, trauma and systemic symptoms. Young age with exercise-induced ischemia should prompt assessment for compression or other non-atherosclerotic causes; cold-related digital episodes suggest a vasospastic disorder; fever, skin manifestations, arthralgia or inflammatory abnormalities may point toward vasculitis or infection. Current treatment, bleeding risk and a history of reactions to contrast agents are included in the assessment from the outset because they will influence investigations and treatment options.
Physical examination begins with general condition, vital signs and comparison of blood pressure in both upper limbs, followed by inspection and palpation of the suspected territories. Pulses, temperature, color, skin trophism, lesions, sensation and strength are assessed; a pulsatile mass may suggest an aneurysm but must not be examined using traumatic maneuvers. Bruits indicate turbulence and do not reliably measure stenosis severity: an occlusive lesion may produce no bruit.
Neurological and abdominal examinations complete the assessment when symptoms warrant them. Absent pulses are an important finding, but palpable pulses do not exclude microembolism or digital vasculopathy. Likewise, an initially unremarkable examination does not exclude early intestinal ischemia. The priority is to recognize threatened tissue before late signs of irreversible damage appear.
No single set of diagnostic criteria applies to all peripheral arterial diseases, because they are not one disease. Diagnosis must connect the anatomical lesion, etiological mechanism and clinical consequence. Suspected obstruction of lower-limb arteries is generally investigated first with noninvasive physiological measurements; acute neurological deficits and suspected mesenteric ischemia instead trigger urgent imaging pathways. Insisting on the same sequence of tests for every vascular territory could delay diagnosis of conditions in which time determines whether recovery is possible.
The ankle-brachial index compares ankle with brachial systolic pressure and is an initial test for obstructive lower-limb arterial disease. A value not exceeding 0.90 is abnormal, whereas noncompressible arteries can produce artificially high values, especially in diabetes and kidney disease. When results are discordant, toe pressures, the toe-brachial index and Doppler waveform analysis are used; when symptoms arise during walking but a resting examination does not resolve the suspicion, exercise testing may be needed. These measurements do not diagnose carotid, renal or mesenteric stenosis and must not be used as universal tests of the arterial tree.
Duplex Doppler ultrasonography combines morphological and velocity information. It allows stenoses and occlusions to be located, flow direction to be observed and aneurysmal dilations to be recognized in many accessible segments. Interpretation requires criteria specific to the vascular territory and vessel examined; calcification, depth, bowel gas and operator skill affect accuracy. Velocity measurement is not interchangeable with a simple anatomical percentage of stenosis and can be misleading when serial lesions or very low flows coexist.
CT angiography and MR angiography define the extent of disease, anatomical relationships and branch involvement, with different strengths and limitations. CT is fast and particularly useful in many emergencies, but involves radiation and, in conventional angiographic acquisitions, iodinated contrast; calcium may interfere with assessment of small lumens. MRI avoids ionizing radiation and also permits noncontrast techniques, but requires device compatibility, patient cooperation and appropriate protocols. Choice depends on the clinical question and renal function, without attributing absolute superiority to one method in every situation.
Catheter angiography is used when noninvasive information is insufficient or when diagnosis and treatment can take place during the same procedure. The ability to intervene does not eliminate its risks: arterial access, embolization, dissection, bleeding and contrast exposure must be justified by a specific clinical decision. For visceral stenoses and certain complex conditions, an image of the lumen alone may require supplementation by hemodynamic assessment. An anatomical finding unrelated to symptoms and organ function is not, by itself, an indication for revascularization.
Blood tests characterize comorbidities, treatment safety and possible causes, but do not replace vascular imaging. Complete blood count, renal function, blood glucose, glycated hemoglobin and lipid profile are often relevant; autoantibodies, inflammatory markers, blood cultures or hematological investigations are selected when there is a specific suspicion. In intestinal ischemia, normal lactate does not exclude an early stage. In suspected embolism, arrhythmias and cardiac sources are sought using electrocardiography, monitoring and echocardiography according to context. In Raynaud phenomenon, capillaroscopy and immunological investigations help distinguish primary from secondary forms.
Once disease is confirmed, its extent and organ damage are defined. In a threatened limb, perfusion, lesion depth and infection must be assessed together; in cervical arterial disease, cerebral parenchyma and event distribution are also important; in renal stenosis, blood pressure, functional trajectory and kidney characteristics matter; in aneurysms, size, morphology, thrombus, symptoms and other at-risk sites are evaluated. Differential diagnoses remain part of the pathway: lumbar spinal stenosis and joint disorders can mimic claudication, neuropathic or venous ulcers can coexist with ischemia, and nonvascular gastrointestinal causes can explain pain and weight loss. Correctly attributing symptoms prevents treatment of an incidental lesion while leaving the main problem unresolved.
Treatment follows the cause and clinical objective. In atherosclerotic disease, cardiovascular risk is addressed through smoking cessation, treatment of atherogenic lipoproteins, blood pressure and metabolic control, appropriate physical activity and antithrombotic agents when indicated. Revascularization corrects a specific flow abnormality but does not remove the systemic exposure that caused the disease. In non-atherosclerotic forms, however, statins and antiplatelet agents must not be prescribed automatically merely because the term “arteriopathy” is present: indications depend on the mechanism, comorbidities and balance of benefit and risk.
Lipid-lowering treatment for documented atherosclerotic disease is based on the maximally tolerated intensity of statin therapy, with combinations as needed to achieve guideline-recommended targets. Diabetes management must include cardiovascular and renal protection rather than focusing only on blood glucose. Regarding thrombosis, platelet inhibition must be distinguished from anticoagulation: cardioembolism due to atrial fibrillation is not prevented with the same regimen used for atherosclerotic claudication. The combination of aspirin and vascular-dose rivaroxaban has supporting evidence in selected atherosclerotic peripheral disease, but increases bleeding and is not a treatment shared by all arteriopathies.
For stable claudication, structured exercise is a treatment for functional limitation. Progressive walking, tailored and monitored, improves exercise capacity and quality of life even without removing the stenosis. Intervention is considered when disability remains significant despite appropriate treatment or when other specific indications are present. In chronic limb-threatening ischemia, the goal changes: to restore perfusion sufficient to promote healing, control pain and preserve a functional limb, together with infection management and wound protection.
Acute limb ischemia requires immediate assessment of tissue viability. Initial anticoagulation, unless contraindicated, and rapid selection among embolectomy, thrombectomy, catheter-directed thrombolysis, surgical reconstruction or combined approaches depend on the cause and neurological threat. An irreversibly damaged limb does not benefit from indiscriminate reperfusion, which may worsen systemic consequences. Similarly, in acute mesenteric ischemia, restoration of blood flow must be coordinated with assessment of intestinal viability and any necessary resection of necrotic tissue.
In carotid artery disease, medical prevention is essential, whereas endarterectomy or endovascular treatment requires selection according to symptoms, stenosis, anatomy, procedural risk and life expectancy. The assessment of atherosclerotic carotid stenosis therefore differs from that of cervical dissection, in which prevention of thromboembolism and monitoring of wall changes have a central role. In atherosclerotic renal artery stenosis, routine stenting has shown no advantage over medical therapy in most patients studied; revascularization is considered in selected situations, especially when clinically relevant and potentially reversible hemodynamic consequences are plausible.
Aneurysms may require surveillance or surgical or endovascular repair, depending on site and complication risk. Decisions are not based on a universal diameter threshold: symptoms, embolization, growth, morphology, pseudoaneurysm status and particular clinical conditions can alter the indication. In fibromuscular dysplasia, treatment of renal artery stenosis may include angioplasty in selected patients; in arterial compression syndromes, correction of the anatomical conflict may be necessary in addition to vessel repair. In thromboangiitis, complete tobacco cessation is decisive, whereas vasculitis and infections require treatment of the underlying process.
Prognosis encompasses at least three distinct outcomes: survival, organ preservation and functional independence. Patency of a reconstructed vessel is not equivalent to wound healing or recovery of walking ability, and a good local result does not eliminate cardiovascular risk in a patient with atherosclerosis. Follow-up therefore assesses symptoms, function, control of modifiable factors, adherence, treatment complications and progression of lesions that require surveillance. The frequency of investigations should depend on the disease and treatment performed, avoiding repeated anatomical assessments without a defined clinical question.
In chronic obstructive forms, frequent consequences are functional limitation and progressively reduced activity. Pain causes people to walk less; deconditioning, loss of strength and comorbidities can worsen disability even if stenosis changes little. When perfusion no longer supports tissue repair, minor trauma or pressure points become persistent ulcers. Diabetes adds neuropathy and changes in the response to injury, so wound severity and pain intensity may differ considerably.
Necrosis may remain localized or be accompanied by deep infection, osteomyelitis and sepsis. Acute ischemia can cause permanent muscle and nerve damage; reperfusion of severely ischemic muscle can release potassium and myoglobin, cause edema and contribute to renal failure, arrhythmias and compartment syndrome. In visceral organs, loss of perfusion may progress to intestinal infarction, perforation and multiorgan failure, or to loss of renal function when parenchymal damage becomes irreversible.
Embolization links proximal lesions with distal events: carotid plaques or dissections may cause stroke, aneurysms and mural thrombi may cause ischemia of the extremities, and atheromatous material may reach small vessels, producing injury disproportionate to changes in the major pulses. Aneurysms can also compress nerves and veins or rupture, causing hemorrhage of variable severity depending on location. The absence of preceding symptoms does not exclude these complications, which sometimes constitute the first manifestation of disease.
In patients with atherosclerosis, myocardial infarction, stroke and cardiovascular death often reflect involvement of multiple vascular territories; they are not simply mechanical consequences of stenosis in one limb. Added to these are treatment risks, such as bleeding from antithrombotics, access-site complications, restenosis, thrombosis of reconstructions and prosthetic infections. The overall assessment must therefore combine local benefit with systemic protection: saving threatened tissue, preserving function and reducing the likelihood of new events are complementary objectives of the same care process.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.